TapewireFind a company

person · Reporting owner

Whitley Richard James

Disclosed activity across 2 companies

Tapewire entity
15653
SEC CIK
0001441661

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Dogwood Therapeutics, Inc.DWTX · Entity 6845DirectorJune 16, 2026June 17, 2026
GILEAD SCIENCES, INC.GILD · Entity 405DirectorMay 06, 2021May 07, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Dogwood Therapeutics, Inc.

Report date June 16, 2026 · Filed June 17, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.50 · Expires 2036-06-16Direct16,800 Reported balance After 2026-06-16 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-06-16 · Grant · Acquired 16,800 · Balance 16,800

GILEAD SCIENCES, INC.

Report date May 06, 2021 · Filed May 07, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect33,058 Reported balance After 2021-05-06 transaction · row 1
1 source row

Row 1 · 2021-05-06 · Exercise / conversion · Acquired 1,936 · Balance 33,058

F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

Restricted Stock UnitSEC Table II · derivative / convertible securityDirect4,028 Reported balance After 2021-05-06 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2021-05-06 · Exercise / conversion · Disposed 1,936 · Balance 4,028

F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2: 100% of the restricted stock units vested on May 6, 2021.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2: 100% of the restricted stock units vested on May 6, 2021.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 16, 2026 Filed Jun 17, 2026 17:17 UTC Dogwood Therapeutics, Inc. DWTX · Entity 6845 GrantStock Option (right to buy) · Derivative 16,800 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0001441661-26-000002 · form4-06172026_050636.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,800

Underlying: Common Stock · 16,800 shares

Expires 2036-06-16

Read SEC document
June 27, 2025 Filed Jul 1, 2025 18:07 UTC Dogwood Therapeutics, Inc. DWTX · Entity 6845 GrantStock Option (right to buy) · Derivative 2,362 $0.00 Strike: $4.71 $0.00
Disclosure

SEC source: 0001415889-25-018651 · form4-07012025_060726.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,362

Underlying: Common Stock · 2,362 shares

Expires 2035-06-27

Read SEC document
June 18, 2025 Filed Jun 23, 2025 16:04 UTC Dogwood Therapeutics, Inc. DWTX · Entity 6845 GrantStock Option (right to buy) · Derivative 210 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001415889-25-017940 · form4-06232025_040610.xml · derivative · entry 2

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 420

Underlying: Common Stock · 210 shares

Expires 2035-06-18

Read SEC document
June 18, 2025 Filed Jun 23, 2025 16:04 UTC Dogwood Therapeutics, Inc. DWTX · Entity 6845 GrantStock Option (right to buy) · Derivative 210 $0.00 Strike: $4.80 $0.00
Disclosure

SEC source: 0001415889-25-017940 · form4-06232025_040610.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210

Underlying: Common Stock · 210 shares

Expires 2035-06-18

Read SEC document
February 26, 2024 Filed Feb 28, 2024 18:04 UTC Dogwood Therapeutics, Inc. VIRI · Entity 6845 GrantStock Option (right to buy) · Derivative 4,000 $0.00 Strike: $0.36 $0.00
Disclosure

SEC source: 0001415889-24-005681 · form4-02282024_060200.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires 2034-02-26

F1 · derivative.exercise_date: The stock option will vest 100% on February 26, 2025, one year following the grant date.

Read SEC document
June 15, 2023 Filed Jun 20, 2023 17:56 UTC Dogwood Therapeutics, Inc. VIRI · Entity 6845 GrantStock Option (right to buy) · Derivative 5,250 $0.00 Strike: $1.85 $0.00
Disclosure

SEC source: 0001415889-23-009985 · form4-06202023_050656.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,250

Underlying: Common Stock · 5,250 shares

Expires 2033-06-15

F1 · derivative.exercise_date: The stock option will vest 100% on June 15, 2024, one year following the grant date.

Read SEC document
December 08, 2022 Filed Dec 12, 2022 18:39 UTC Dogwood Therapeutics, Inc. VIRI · Entity 6845 SaleCommon Stock 1,800 $0.26 $466.38
Disclosure

SEC source: 0001415889-22-012370 · form4-12122022_061240.xml · nonDerivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 700

Read SEC document
June 23, 2022 Filed Jun 30, 2022 18:09 UTC Dogwood Therapeutics, Inc. VIRI · Entity 6845 GrantStock Option (right to buy) · Derivative 5,250 $0.00 Strike: $4.23 $0.00
Disclosure

SEC source: 0001415889-22-007096 · form4-06302022_110649.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,250

Underlying: Common Stock · 5,250 shares

Expires 2032-06-23

F1 · derivative.exercise_date: The stock option will vest 100% on June 23, 2023, one year following the grant date.

Read SEC document
May 18, 2022 Filed May 19, 2022 15:48 UTC Dogwood Therapeutics, Inc. VIRI · Entity 6845 PurchaseCommon Stock 500 $4.53 $2,262.50
Disclosure

SEC source: 0001415889-22-005275 · form4-05192022_080533.xml · nonDerivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Read SEC document
January 06, 2022 Filed Jan 7, 2022 18:14 UTC Dogwood Therapeutics, Inc. VIRI · Entity 6845 PurchaseCommon Stock 1,800 $5.72 $10,296.00
Disclosure

SEC source: 0001415889-22-000447 · form4-01072022_100133.xml · nonDerivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Read SEC document
December 23, 2021 Filed Dec 23, 2021 20:59 UTC Dogwood Therapeutics, Inc. VIRI · Entity 6845 PurchaseCommon Stock 200 $5.73 $1,145.00
Disclosure

SEC source: 0001415889-21-006204 · form4-12232021_121238.xml · nonDerivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200

Read SEC document
June 22, 2021 Filed Jun 23, 2021 18:55 UTC Dogwood Therapeutics, Inc. VIRI · Entity 6845 GrantStock Option (right to buy) · Derivative 7,875 $0.00 Strike: $6.50 $0.00
Disclosure

SEC source: 0001415889-21-003154 · form4-06232021_110634.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,875

Underlying: Common Stock · 7,875 shares

Expires 2031-06-22

F1 · derivative.exercise_date: The stock option will vest in 12 equal monthly installments following the grant date.

Read SEC document
May 06, 2021 Filed May 7, 2021 22:53 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionRestricted Stock Unit · Derivative 1,936 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-015952 · form4.xml · derivative · entry 2

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,028

Underlying: Common Stock · 1,936 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 6, 2021.

F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 6, 2021.

Read SEC document
May 06, 2021 Filed May 7, 2021 22:53 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 1,936 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-21-015952 · form4.xml · nonDerivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,058

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

Read SEC document
May 03, 2021 Filed May 4, 2021 22:37 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 20,282 $0.00 Strike: $20.65 $0.00
Disclosure

SEC source: 0001127602-21-015340 · form4.xml · derivative · entry 3

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,282 shares

Expires 2021-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options vested quarterly over the first year of service and were fully vested on May 12, 2012.

Read SEC document
May 03, 2021 Filed May 4, 2021 22:37 UTC GILEAD SCIENCES, INC. GILD · Entity 405 SaleCommon Stock 20,282 $64.57 $1,309,655.39
Disclosure

SEC source: 0001127602-21-015340 · form4.xml · nonDerivative · entry 2

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,122

F1 · price: Sale prices reported for the transactions reported here range from $64.56 to $64.64. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

Read SEC document
May 03, 2021 Filed May 4, 2021 22:37 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 20,282 $20.65 $418,721.89
Disclosure

SEC source: 0001127602-21-015340 · form4.xml · nonDerivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,404

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 30, 2021 Filed Mar 31, 2021 23:47 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 62.9649 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-21-012440 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,871.6977

Underlying: Common Stock · 62.9649 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
December 30, 2020 Filed Jan 4, 2021 18:24 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 68.8983 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-21-000084 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,808.7328

Underlying: Common Stock · 68.8983 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 23:09 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionPhantom Stock · Derivative 1,434 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-20-026596 · form4.xml · derivative · entry 2

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,739.8344

Underlying: Common Stock · 1,434 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: An aggregate of 1434.958608 shares were reported in Table II when the reporting person acquired the phantom shares. The fractional share of 0.958608 was paid out in cash in connection with the conversion into shares of common stock.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
October 01, 2020 Filed Oct 5, 2020 23:09 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 1,434 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-026596 · form4.xml · nonDerivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,122

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

Read SEC document
September 29, 2020 Filed Oct 1, 2020 21:20 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 77.7136 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-20-026051 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,174.793

Underlying: Common Stock · 77.7136 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
June 29, 2020 Filed Jul 1, 2020 21:03 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 64.1416 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-20-020666 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,097.0794

Underlying: Common Stock · 64.1416 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
May 06, 2020 Filed May 8, 2020 00:30 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantNon-qualified Stock Option (Right to Buy) · Derivative 7,886 $0.00 Strike: $77.47 $0.00
Disclosure

SEC source: 0001127602-20-015845 · form4.xml · derivative · entry 4

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,886

Underlying: Common Stock · 7,886 shares

Expires 2030-05-06

F4 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary from May 6, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 6, 2021 or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
May 06, 2020 Filed May 8, 2020 00:30 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantRestricted Stock Unit · Derivative 1,936 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-015845 · form4.xml · derivative · entry 3

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,964

Underlying: Common Stock · 1,936 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2021 or the day immediately preceding the next regular annual stockholders meeting.

F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2021 or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
May 05, 2020 Filed May 8, 2020 00:30 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionRestricted Stock Unit · Derivative 2,270 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-015845 · form4.xml · derivative · entry 2

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,028

Underlying: Common Stock · 2,270 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 5, 2020.

F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 5, 2020.

Read SEC document
May 05, 2020 Filed May 8, 2020 00:30 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 2,270 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-015845 · form4.xml · nonDerivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,688

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

Read SEC document
March 30, 2020 Filed Apr 1, 2020 18:20 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 62.4252 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-20-012372 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,032.9378

Underlying: Common Stock · 62.4252 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
December 30, 2019 Filed Jan 2, 2020 21:30 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 66.9833 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-20-000167 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,970.5126

Underlying: Common Stock · 66.9833 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
September 27, 2019 Filed Oct 1, 2019 00:04 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 68.4594 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-19-029286 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,903.5293

Underlying: Common Stock · 68.4594 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
June 27, 2019 Filed Jul 1, 2019 23:40 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 63.5961 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-19-023299 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,835.07

Underlying: Common Stock · 63.5961 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
May 08, 2019 Filed May 10, 2019 21:24 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantNon-qualified Stock Option (Right to Buy) · Derivative 11,848 $0.00 Strike: $66.07 $0.00
Disclosure

SEC source: 0001127602-19-018180 · form4.xml · derivative · entry 2

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,848

Underlying: Common Stock · 11,848 shares

Expires 2029-05-08

F3 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary from May 8, 2019 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 8, 2020 or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
May 08, 2019 Filed May 10, 2019 21:24 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantRestricted Stock Unit · Derivative 2,270 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-19-018180 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,298

Underlying: Common Stock · 2,270 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 8, 2020, or the day immediately preceding the next regular annual stockholders meeting.

F2 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 8, 2020, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
May 07, 2019 Filed May 8, 2019 22:42 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionRestricted Stock Unit · Derivative 2,283 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-19-017787 · form4.xml · derivative · entry 2

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,028

Underlying: Common Stock · 2,283 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · derivative.exercise_date: 100% of the restricted stock units vested on May 7, 2019.

F2 · derivative.expiration_date: 100% of the restricted stock units vested on May 7, 2019.

Read SEC document
May 07, 2019 Filed May 8, 2019 22:42 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 2,283 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-19-017787 · form4.xml · nonDerivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,418

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

Read SEC document
May 01, 2019 Filed May 2, 2019 22:48 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 9,534 $0.00 Strike: $22.02 $0.00
Disclosure

SEC source: 0001127602-19-017100 · form4.xml · derivative · entry 3

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,534 shares

Expires 2019-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The options vested quarterly over the first year of service and were fully vested on May 6, 2010.

Read SEC document
May 01, 2019 Filed May 2, 2019 22:48 UTC GILEAD SCIENCES, INC. GILD · Entity 405 SaleCommon Stock 9,534 $65.02 $619,934.05
Disclosure

SEC source: 0001127602-19-017100 · form4.xml · nonDerivative · entry 2

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,135

F2 · price: Sale prices reported for the transactions reported here range from $64.49 to $65.47. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

Read SEC document
May 01, 2019 Filed May 2, 2019 22:48 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 9,534 $22.02 $209,891.01
Disclosure

SEC source: 0001127602-19-017100 · form4.xml · nonDerivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,669

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 00:10 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 9,534 $0.00 Strike: $22.02 $0.00
Disclosure

SEC source: 0001127602-19-014356 · form4.xml · derivative · entry 3

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,534

Underlying: Common Stock · 9,534 shares

Expires 2019-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The options vested quarterly over the first year of service and were fully vested on May 6, 2010.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 00:10 UTC GILEAD SCIENCES, INC. GILD · Entity 405 SaleCommon Stock 9,534 $65.48 $624,254.86
Disclosure

SEC source: 0001127602-19-014356 · form4.xml · nonDerivative · entry 2

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,135

F2 · price: Sale prices reported for the transactions reported here range from $65.25 to $65.67. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

Read SEC document
April 01, 2019 Filed Apr 3, 2019 00:10 UTC GILEAD SCIENCES, INC. GILD · Entity 405 Exercise / conversionCommon Stock 9,534 $22.02 $209,891.01
Disclosure

SEC source: 0001127602-19-014356 · form4.xml · nonDerivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,669

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 28, 2019 Filed Apr 1, 2019 23:16 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 66.3251 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-19-013909 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,771.4738

Underlying: Common Stock · 66.3251 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
December 28, 2018 Filed Jan 2, 2019 22:21 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 61.1999 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-19-000353 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,705.1488

Underlying: Common Stock · 61.1999 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
September 27, 2018 Filed Oct 1, 2018 22:55 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 49.0869 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-18-028859 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,643.9489

Underlying: Common Stock · 49.0869 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
June 28, 2018 Filed Jul 2, 2018 23:51 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 53.0193 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-18-022355 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,594.862

Underlying: Common Stock · 53.0193 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
May 09, 2018 Filed May 11, 2018 23:15 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantRestricted Stock Unit · Derivative 2,283 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-18-017245 · form4.xml · derivative · entry 2

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,311

Underlying: Common Stock · 2,283 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F2 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2019, or the day immediately preceding the next regular annual stockholders meeting.

F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 9, 2019, or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
May 09, 2018 Filed May 11, 2018 23:15 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantNon-qualified Stock Option (Right to Buy) · Derivative 9,496 $0.00 Strike: $65.69 $0.00
Disclosure

SEC source: 0001127602-18-017245 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,496

Underlying: Common Stock · 9,496 shares

Expires 2028-05-09

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary measured from May 9, 2018 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 9, 2019 or the day immediately preceding the next regular annual stockholders meeting.

Read SEC document
March 29, 2018 Filed Apr 2, 2018 23:32 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 49.0897 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-18-013414 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,541.8427

Underlying: Common Stock · 49.0897 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
December 28, 2017 Filed Jan 2, 2018 23:32 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 46.2497 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-18-000222 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,492.753

Underlying: Common Stock · 46.2497 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document
September 28, 2017 Filed Oct 2, 2017 23:59 UTC GILEAD SCIENCES, INC. GILD · Entity 405 GrantPhantom Stock · Derivative 41.1664 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001127602-17-028703 · form4.xml · derivative · entry 1

Whitley Richard James · CIK 0001441661 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,446.5033

Underlying: Common Stock · 41.1664 shares

Expires not disclosed

F1 · security: Each share of phantom stock is the economic equivalent of one share of Gilead common stock.

F2 · shares: Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.

F3 · derivative.exercise_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

F3 · derivative.expiration_date: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.